Keywords: Non-Proton, Pediatric, Brain tumor, 7T, Neuro, 31P
Motivation: Treatment monitoring in pediatric brain tumors is often challenging. Non-invasive tools are needed to assess tumor activity accurately.
Goal(s): To monitor changes in phospholipid metabolism (i.e., phosphomonoesters/phosphodiesters [PME/PDE]) in pediatric low grade gliomas.
Approach: Eleven pediatric brain tumor patients underwent 31P-MRSI at 7T. PME/PDE in the tumor was compared to a normal-appearing brain voxel. Clinical outcomes were assessed, and results were compared between treatment and wait-and-scan groups.
Results: Tumors selected for treatment showed higher PME/PDE ratios at baseline, hinting at potential aggressiveness. These ratios decreased during treatment but remained stable in the wait-and-scan group.
Impact: Treatment monitoring in pediatric brain tumors is often challenging. Using 31P-MRSI we showed that tumors selected for treatment exhibited higher PME/PDE, signifying potential tumor aggressiveness. PME/PDE levels decreased during treatment, indicating potential for non-invasive assessment of treatment effects.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords